Utah Medical Products (NASDAQ: UTMD) and Lombard Medical (OTCMKTS:EVARF) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations and risk.

Valuation and Earnings

This table compares Utah Medical Products and Lombard Medical’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Utah Medical Products $39.30 million 7.86 $12.12 million $3.68 22.55
Lombard Medical $12.17 million 0.32 -$31.03 million ($1.54) -0.09

Utah Medical Products has higher revenue and earnings than Lombard Medical. Lombard Medical is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Utah Medical Products and Lombard Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Utah Medical Products 34.31% 18.31% 16.40%
Lombard Medical N/A N/A N/A

Institutional and Insider Ownership

66.7% of Utah Medical Products shares are owned by institutional investors. Comparatively, 39.9% of Lombard Medical shares are owned by institutional investors. 9.1% of Utah Medical Products shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Risk and Volatility

Utah Medical Products has a beta of 0.78, indicating that its stock price is 22% less volatile than the S&P 500. Comparatively, Lombard Medical has a beta of 1.47, indicating that its stock price is 47% more volatile than the S&P 500.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Utah Medical Products and Lombard Medical, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Utah Medical Products 0 0 0 0 N/A
Lombard Medical 0 0 0 0 N/A

Dividends

Utah Medical Products pays an annual dividend of $1.08 per share and has a dividend yield of 1.3%. Lombard Medical does not pay a dividend. Utah Medical Products pays out 29.3% of its earnings in the form of a dividend.

Summary

Utah Medical Products beats Lombard Medical on 11 of the 13 factors compared between the two stocks.

Utah Medical Products Company Profile

Utah Medical Products, Inc. (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts. UTMD markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit, the labor and delivery department and the women’s health center in hospitals, as well as products sold to outpatient clinics and physician’s offices.

Lombard Medical Company Profile

Lombard Medical, Inc. is a medical technology company. The Company specializes in developing, manufacturing, and marketing endovascular stent-grafts that address medical needs in the repair of aortic aneurysms. The Company’s Aorfix is an abdominal aortic aneurysm (AAA) stent-graft for the treatment of AAAs with angulation at the neck of the aneurysm of over 90 degrees. The Company supplies Aorfix pre-loaded into a delivery system, Aorflex, which is designed for accurate placement of Aorfix in the abdominal aorta. Once Aorfix is properly placed within the abdominal aorta, it provides a conduit for blood flow, thereby relieving pressure within the weakened or aneurysmal section of the vessel wall, which reduces the potential for the AAA to rupture. It also offers IntelliFlex, which is a delivery system technology created for Aorfix AAA stent graft, and Altura Endovascular Stent Graft System that offers a simple and predictable solution to the treatment of standard AAA anatomies.

Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.